- Headquarters
- Ithaca, New York
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- ascribebio.com
- Total Funding
- $13.0M
- Last Round
- $12.0M Series AOct 2025
- Rounds
- 6
About
Ascribe Bioscience is an Ithaca, NY-based agricultural biotechnology company developing natural crop protection solutions derived from small molecules discovered in the soil microbiome. Founded in 2017 from research at the Boyce Thompson Institute and Cornell University, Ascribe's platform applies metabolomics to identify bioactive compounds that prime plant immune systems against crop pathogens. Its flagship product, Phytalix, is a biofungicide that delivers the sustainability benefits of biologicals with the efficacy and ease of use of conventional chemical crop protection, targeting diseases including Bacterial Leaf Blight in rice. The company raised a $12 million Series A in October 2025 to advance its next-generation product pipeline.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Oct 2025
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company